ACUTAAS.NS Balance Sheet
Acutaas Chemicals Ltd.
Profit & Loss Balance Sheet Cash Flow
Balance Sheet · 4 years on file
(FY2022-23 to FY2025-26)
· fetched 2026-08-23 21:32
| Line item | FY2022-23 | FY2023-24 | FY2024-25 | FY2025-26 | Source (XBRL element) |
|---|---|---|---|---|---|
| Property, Plant and Equipment | ₹221.77 Cr. | ₹360.06 Cr. | ₹505.31 Cr. | ₹633.32 Cr. | PropertyPlantAndEquipment |
| Capital Work-in-Progress | ₹25.52 Cr. | ₹125.42 Cr. | ₹130.28 Cr. | ₹332.32 Cr. | CapitalWorkInProgress |
| Goodwill | ₹20.32 Cr. | ₹56.80 Cr. | ₹56.80 Cr. | ₹104.34 Cr. | Goodwill |
| Other Intangible Assets | ₹16.86 Cr. | ₹10.30 Cr. | ₹8.28 Cr. | ₹7.19 Cr. | OtherIntangibleAssets |
| Non-current Investments | ₹1.65 Cr. | ₹0.20 Cr. | ₹0.20 Cr. | ₹0.20 Cr. | NoncurrentInvestments |
| Other Non-current Assets | N/A | ₹44.73 Cr. | ₹51.82 Cr. | ₹17.10 Cr. | OtherNoncurrentAssets |
| Total Non-current Assets | ₹296.86 Cr. | ₹600.09 Cr. | ₹757.63 Cr. | ₹1,102.69 Cr. | NoncurrentAssets |
| Inventories | ₹119.17 Cr. | ₹156.73 Cr. | ₹179.94 Cr. | ₹231.32 Cr. | Inventories |
| Trade Receivables | ₹230.26 Cr. | ₹206.35 Cr. | ₹290.49 Cr. | ₹362.56 Cr. | TradeReceivablesCurrent |
| Cash and Cash Equivalents | ₹30.53 Cr. | ₹29.70 Cr. | ₹185.22 Cr. | ₹215.55 Cr. | CashAndCashEquivalents |
| Current Investments | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | CurrentInvestments |
| Other Current Assets | ₹57.42 Cr. | ₹75.35 Cr. | ₹0.00 Cr. | N/A | OtherCurrentAssets |
| Total Current Assets | ₹470.08 Cr. | ₹495.81 Cr. | ₹791.64 Cr. | ₹881.27 Cr. | CurrentAssets |
| Total Assets | ₹766.94 Cr. | ₹1,095.90 Cr. | ₹1,549.26 Cr. | ₹1,983.96 Cr. | Assets |
| Equity Share Capital | ₹36.44 Cr. | ₹36.88 Cr. | ₹40.93 Cr. | ₹40.94 Cr. | EquityShareCapital |
| Other Equity | ₹557.52 Cr. | ₹637.12 Cr. | ₹1,268.69 Cr. | ₹1,612.63 Cr. | OtherEquity |
| Equity Attributable to Owners | ₹593.96 Cr. | ₹674.00 Cr. | ₹1,309.63 Cr. | ₹1,653.56 Cr. | EquityAttributableToOwnersOfParent |
| Non-controlling Interests | N/A | ₹8.76 Cr. | ₹10.45 Cr. | ₹57.19 Cr. | NonControllingInterest |
| Total Equity | ₹593.96 Cr. | ₹682.76 Cr. | ₹1,320.08 Cr. | ₹1,710.75 Cr. | Equity |
| Long-term Borrowings | ₹0.63 Cr. | ₹113.64 Cr. | ₹0.00 Cr. | ₹0.00 Cr. | BorrowingsNoncurrent |
| Total Non-current Liabilities | ₹10.13 Cr. | ₹127.98 Cr. | ₹26.93 Cr. | ₹42.40 Cr. | NoncurrentLiabilities |
| Short-term Borrowings | ₹2.97 Cr. | ₹103.01 Cr. | ₹8.18 Cr. | ₹26.49 Cr. | BorrowingsCurrent |
| Trade Payables | ₹142.05 Cr. | ₹134.61 Cr. | ₹156.05 Cr. | ₹153.91 Cr. | TradePayablesCurrent |
| Other Current Liabilities | ₹6.43 Cr. | ₹34.36 Cr. | ₹13.48 Cr. | ₹12.44 Cr. | OtherCurrentLiabilities |
| Total Current Liabilities | ₹162.85 Cr. | ₹285.17 Cr. | ₹202.25 Cr. | ₹230.81 Cr. | CurrentLiabilities |
| Total Equity and Liabilities | ₹766.94 Cr. | ₹1,095.90 Cr. | ₹1,549.26 Cr. | ₹1,983.96 Cr. | EquityAndLiabilities |
Every figure above is the exact value of the named XBRL element from ACUTAAS.NS's cached filing for that year — nothing here is estimated or backfilled. A company shows one column per year StockProof actually has data for — never padded with blank years. Rows shown as N/A are genuinely not disclosed under that year's filing format (see peer comparison for how other Healthcare companies compare).